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Abstract
Background: Various international studies have shown that a substantial number of patients suffer
from injuries or even die as a result of care delivered in hospitals. The occurrence of injuries among
patients caused by health care management in Dutch hospitals has never been studied
systematically. Therefore, an epidemiological study was initiated to determine the incidence, type
and impact of adverse events among discharged and deceased patients in Dutch hospitals.
Methods/Design: Three stage retrospective patient record review study in 21 hospitals of 8400
patient records of discharged or deceased patients in 2004. The records were reviewed by trained
nurses and physicians between August 2005 and October 2006. In addition to the determination
of presence, the degree of preventability, and causes of adverse events, also location, timing,
classification, and most responsible specialty of the adverse events were measured. Moreover,
patient and admission characteristics and the quality of the patient records were recorded.
Discussion: In this paper we report on the design of the retrospective patient record study on
the occurrence of adverse events in Dutch hospitals. Attention is paid to the strengths and
limitations of the study design. Furthermore, alterations made in the original research protocol in
comparison with former international studies are described in detail.
Background
Various studies have shown that a substantial number of
patients suffer from injuries or even die as a result of care
delivered in hospitals [1-11]. The studies revealed that
2.9% to 16.6% of patients in acute care hospitals experi-
enced one or more adverse events and that in 5% to 13%
of the adverse events patients died. Approximately 50% of
the adverse events were considered as preventable. An
adverse event is defined as an unintended injury that
results in disability at the time of discharge, death, or pro-
longed hospital stay and is caused by health care manage-
ment rather than by the patient's underlying disease
process [1,3,9,11]. The large variation in the incidence of
adverse events among the studies in different countries
may either be explained by true differences in patient
safety of the different health care systems, or by methodo-
logical differences between the studies. Therefore, extrap-
olation of results from other countries will not give a valid
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estimate of patient safety in health care in e.g. Dutch hos-
pitals.
The occurrence of injuries among patients caused by
health care management in Dutch hospitals has never
been studied systematically. Analysis of complaints, com-
plications, medical errors and incidents recorded in Dutch
hospitals and taken from data on claims and disciplinary
proceedings, has shown – not surprisingly – that adverse
events are occurring in Dutch hospitals [12-14] However,
such data are inappropriate to estimate the incidence of
adverse events, because completeness of the registrations
depends on the willingness to report in the hospitals and
a standardisation of the registration systems is lacking.
Therefore, in 2005, as first part of the Dutch Patient Safety
Research Program, a study was initiated to determine the
incidence, nature, type, impact and costs of adverse events
among hospitalised patients in the Netherlands. Insight in
preventable adverse events can offer a starting point for
specific interventions to improve patient safety in hospi-
tals.
The method used in this study was based on a protocol
originally developed by the Harvard Medical Practice
Study, which has studied the incidence of adverse events
in New York state hospitals in 1984, based on analysis of
information in patient records [2]. This protocol, with
modifications, was used in subsequent studies in Aus-
tralia, the United Kingdom, New Zealand, the United
States (in Colorado and Utah), Denmark, France and
Canada [1-3,6,8-11,15] The protocol and instruments
used in this Dutch study are based on the most recent ret-
rospective study of adverse events in hospitals, which was
carried out in Canada. A pilot study showed that the
method and instruments, with some modifications, were
valid and appropriate for the study of adverse events in
Dutch hospitals [16]. However, our pilot study showed
moderate to poor inter-rater reliability in the determina-
tion of adverse events and their preventability. Also in the
previous studies inter-rater reliability appeared to be a
major problem [1-3,9,11,17-19] Therefore, standing on
the shoulders of our predecessors and keeping the method
and instruments maximally comparable, we have tried to
improve the reliability of the adverse events determina-
tion.
The retrospective patient record study is the first epidemi-
ological study on the occurrence of adverse events in
Dutch hospitals. The objectives of this study are to (1)
determine the incidence, nature, type, impact, and costs of
adverse events among hospitalised discharged and
deceased patients; (2) examine the causes and preventa-
bility of these adverse events; (3) compare the rate of
adverse events and preventable deaths between hospital
types and between main specialties; and (4) compare the
Dutch incidence of adverse events in acute care hospitals
with international rates.
In this paper we report on the design of the retrospective
patient record study on the occurrence of adverse events in
Dutch hospitals. Attention is paid to the strengths and
limitations of the study design. Furthermore, alterations
made in the original research protocol in comparison
with former international studies are described in detail.
The results will be published in a separate article.
Methods/Design
Design and setting
The study is a retrospective patient record study carried
out in Dutch hospitals. Patient records of randomly
selected admissions of patients discharged in 2004 and
admissions of patients who died in the hospital in 2004
were reviewed in a three stage review process by nurses
and physicians between August 2005 and October 2006.
Definitions
The definitions used in this study were adopted from pre-
vious adverse event studies to enable a comparison of the
results of this study with previous international studies.
[1,3,9,11]. The definitions are mentioned in table 1. Table
2 gives examples of cases with and without adverse events
and preventability.
Power calculation
The selection of hospital admissions was stratified for
admissions of patients discharged alive and admissions of
patients who died in the hospital. In patients who died
during admission, the incidence of preventable adverse
events associated with the death of the patient was
assessed. Moreover, the incidence of adverse events was
expected to be higher in this group, which made the study
more efficient.
The power calculation of this study was based on the
results of the Canadian adverse event study [1]. Assuming
an incidence of adverse events during hospital admission
of 8%, a sample of 4200 hospital admissions of dis-
charged patients and a sample of 4200 admissions of
deceased patients were necessary to detect an one-side dif-
ference of 1% with the reference value with a power of
0.80 and an alpha from 0.05. Because of difference in
patient mix and delivery of care, we expected a difference
in incidence between hospitals. Therefore, the incidence
per hospital type was measured. To measure the difference
in incidence between hospital types a selection of 800
hospital admissions per hospital type were necessary to
detect a difference from 2% to 3% by an incidence
between 3% and 7%.BMC Health Services Research 2007, 7:27 http://www.biomedcentral.com/1472-6963/7/27
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Hospital selection
To determine a national wide adverse events incidence
rate a random sample of 21 hospitals, which is 20% of the
hospitals in the Netherlands, was selected following strat-
ification by hospital type and geographical area taken the
density of population per region into account. The
selected hospitals were: 4 university hospitals (out of 8), 6
tertiary medical teaching hospitals (out of 19) and 11 gen-
eral hospitals (out of 74). The participating hospitals were
randomly selected from all acute care hospitals in the
Netherlands. Inclusion criteria for the hospitals were: a
minimum of 200 beds, an emergency department and an
intensive care department. Specialty and psychiatric hos-
pitals were not included. If a selected hospital had more
than one location, all locations of the hospital were taken
into account for patient record selection.
Admission selection and record collection
A sample of 8400 admissions was selected: 4200 admis-
sions of hospitalised patients and 4200 admissions of
patients who died during the admission in 2004. Admis-
sions with a diagnosis most related to obstetrics or psychi-
atry and admissions of children younger than 1 year old
were excluded. The method and instruments were consid-
ered inappropriate for these medical specialties. Of each
hospital a random sample of 200 admissions of patients
discharged alive (admissions less than 1 day were
excluded) and 200 admissions of deceased patients were
selected with the hospital information system (inpatient
database). For both patient groups 50 extra admissions
were selected which could be used in case of missing
patient files. One admission, the index admission, per
patient was included. In order to assess the representative-
Table 2: Examples of cases with and without adverse events and preventability
No Adverse event (outcome of disease) [25]
An 80-year-old man presented with a myocardial infarction with three hours of chest pain. He was treated promptly with streptokinase, heparin 
and aspirin. On day 3 he had further chest pain, with new ECG changes, and he died 12 hours later of cardiogenic shock.
Adverse event (no preventability) [11]
A 50-year old woman underwent coronary angiography for unstable angina. During the angiogram she sustained an anaphylactic reaction to the 
contrast, with cardiac arrest. She was able to be resuscitated promptly, without permanent sequelae, and hospitalisation was prolonged by 10 days. 
Evidence for prior contrast reactions was sought and not found.
Adverse event (no preventability) [1]
Abdominal pain and fever following elective surgical procedure. Patient readmitted for antibiotic treatment.
Adverse events (low preventable) [25]
Young right handed man sustained a fracture of the radius within the wrist joint. It required operative reduction, K-wire fraction and bone grafting. 
At the 10-day check the position had shifted and re-operation was required. The end result was very good.
Adverse event (high preventability) [11]
A 67-year old woman underwent a laparoscopic cholecystectomy, which proceeded to an open operation. Endoscopic retrograde 
cholangiopancreatography was undertaken eight days after the operation to remove a gallstone in the common bile duct; cannulation was not 
possible and the procedure was aborted. Ten days after the operation the patient collapsed and died suddenly. Autopsy findings showed extensive 
deep venous thrombosis and saddle pulmonary embolus. There was no documented evidence of thromboembolic prophylaxis in the medical 
record.
Adverse event (high preventability) [1]
Admission because of severe anaemia. The anaemia had been documented in previous admission but not investigated fully, which resulted in delayed 
diagnosis of colorectal carcinoma.
Table 1: Definitions
An adverse event is an unintended injury that results in temporary or permanent disability, death or prolonged hospital stay and that is caused by 
health care management rather than by the patient's underlying disease process.
Unintended Injury refers to any disadvantage for the patient that leads to prolonged or strengthened treatment, temporary or permanent 
(physical or mental) impairment or death.
Disability refers to temporary or permanent impairment of physical or mental function attributable to the adverse event (including prolonged or 
strengthened treatment, prolonged hospital stay, readmission, subsequent hospitalisation, extra outpatient department consultations or death).
Causation refers to injury caused by health care management including acts of omission (inactions) i.e. failure to diagnose or treat, and acts of 
commission (affirmative actions) i.e. incorrect diagnosis or treatment, or poor performance.
Health Care management includes the actions of individual hospital staff as well as the broader systems and care processes. Health care 
management is any care related activity that involves the delivery of care or monitoring of health which is provided by individuals or a team of 
professionals.
Preventable adverse event is an adverse event resulting from an error in management due to failure to follow accepted practice at an individual 
or system level. Accepted practice was taken to be 'the current level of expected performance for the average practitioner or system that manages 
the condition in question'.BMC Health Services Research 2007, 7:27 http://www.biomedcentral.com/1472-6963/7/27
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ness of the selected admissions per hospital, the distribu-
tion of gender, age, admission duration, most responsible
specialty and diagnosis of the admissions were compared
with the pattern for all admissions in the hospital in 2004.
Of the selected index admissions the medical and nursing
records, and if available the outpatient records, were col-
lected. Admissions without nursing or medical records
were excluded in this study and reasons why records were
missing were recorded. The composition of the records
was not uniform in all participating hospitals. Some hos-
pitals had all (medical, nursing and outpatient) records in
one document archived in a central medical archive.
Other hospitals had separate records archived on various
departments. Outpatient records that were archived on
multiple locations were not involved for logistic consider-
ations. In two hospitals the records were scanned and dis-
played on a computer screen.
Reviewer recruitment and training
The patient records were reviewed by a team of 66 nurses
and 55 physicians. The team of recruited physicians con-
sisted of 25 general internists, 20 general surgeons, 5 neu-
rologists and 5 paediatricians. Most were recently retired.
Recruitment of the physicians started through personal
contacts of the project leader and was extended with con-
tacts with the scientific association of internal medicine,
surgery, neurology and paediatrics. The selection criteria
for physicians were:
￿ at least ten years post graduate general clinical experi-
ence;
￿ good reputation among colleagues;
￿ no longer than five years retired;
￿ experience or affinity with analysis of incidents, com-
plaints and errors;
￿ availability for at least one but preferably two days per
week.
The nurses were recruited via the website of the associa-
tion for nurses and websites of hospitals. The selection cri-
teria for the nurses were:
￿ minimum five years clinical experience;
￿ experience or affinity with analysis of incidents, com-
plaints and errors;
￿ availability for at least one, but preferably two days per
week.
An additional expert panel of 18 physicians from other
(sub)specialties was recruited to serve as experts for
advices about accepted clinical practice. These specialists
were authorities within their specialization and were
recruited by the scientific associations of medical special-
ists. The panel consisted of specialists from all involved
medical disciplines in the study. During the review proc-
ess the physicians could get advice about accepted clinical
practice from these authorities.
The nurses and physicians followed a one-day training in
small groups (max 12 participants) led by one member of
the research team and one experienced nurse or physician,
respectively. During the training, the study protocol, defi-
nitions and review forms were explained and examples of
(preventable) adverse events were discussed. The review-
ers practiced with cases and the review forms and they
were provided with a review manual. At the end of the
training the nurses underwent a reliability test. After one
month of reviewing, the reviewers had a half-day training
session to discuss their problems concerning the review
process and definitions and to update the reviewers with
the latest insights about the review process. These training
sessions were frequently repeated during data collection.
The discussed problems were collected in a regularly
updated Frequently Asked Questions (FAQ) document
which was regularly handed out to all reviewers.
The reviewers were compensated for their review activities
at an hourly rate and for expenses.
Review process
At each hospital, the patient records were reviewed in a
three stage review process (Figure 1). In the first stage,
nurses reviewed the complete nursing record from the
selected index admission for the presence of one or more
of 18 screening criteria known to be sensitive to the occur-
rence of an adverse event (table 3). If one or more screen-
ing criteria were found in the nursing record, the case was
forwarded to the second stage of the review procedure. In
case no screening criteria were found in the nursing
record, the nurse also studied the medical record. The
screening criteria in the records were marked with self-
stick notes.
The records with one or more screening criteria were
reviewed by two physicians of the same specialty (general
internists, general surgeons, neurologists or paediatri-
cians) in the second stage of the review process. They
reviewed the records independently and they determined
whether an adverse event had occurred and whether the
adverse event had been preventable with an extended sec-
ond stage review form. If the physician determined an
adverse event, the review was continued with questions
about the nature and impact of the adverse event; locationBMC Health Services Research 2007, 7:27 http://www.biomedcentral.com/1472-6963/7/27
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Diagram of the review process Figure 1
Diagram of the review process.
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and involved specialty; classification, preventability and
causes of the adverse event.
If there was disagreement about the presence of an adverse
event and/or preventability score between the two inde-
pendent physicians, they started a consensus procedure
(stage 3). In this consensus procedure the physicians con-
sidered and discussed both reviews and reconsidered their
reviews in order to come to consensus. When there was
still no agreement, a third trained reviewer gave a final
judgement based on his own judgement and information
of the other two reviewers.
During the second and third stage of the review process
the physicians could ask advice from the 18 specialists in
the expert panel about accepted clinical practice outside
their professional competence, in order to improve their
own judgement of the presence of adverse events and their
preventability.
Electronic review forms
The stage 1 and stage 2 review forms were paper based
instruments converted into electronic templates in a
highly secured web-based program called ProMIse [20]. In
the hospitals, the reviewers filled in the electronic review
forms with a computer connected to internet. Beforehand,
general characteristics of all selected index admissions and
patients were entered in the database. With a protected
internet connection, the sampled data from the record
review entered into ProMIse were immediately transferred
and stored in a central database. No additional software
was required. This way, no patient data on paper or port-
able electronic devices were left in the hospitals. In addi-
tion, working with electronic forms improved the
efficiency of the data collection process and facilitated
quality checks during data collection. The reviewers were
trained to use this web-based program and received a
manual for working with ProMIse. A helpdesk for techni-
cal problems was continuously available. The review
forms on paper (in Dutch) are available from the author.
Premises in participating hospitals
Some preparations were necessary before starting the
study in the hospital. Authorisation of the governing
board and the medical staff was a first condition. Further,
selection of a random sample of patient admissions in
2004 from the hospital information system had to be per-
formed by a hospital employee in cooperation with a
member of the research team. After the sample had
proven to be representative of all hospital admissions,
employees of the archive departments started searching
for the records. In some hospitals, laboratory and radiol-
ogy results were stored separately in an electronic data-
base to which access had to be arranged. During the
review period a minimum of two computers with internet
connection were needed in a separate room in the hospi-
tal that could be locked. A member of the research team
managed the review process and arranged the records in
the hospitals.
Reliability study
To assess the variation of the review process between
reviewers, a random sample of 5% of the records were
independently reviewed by two nurses in the first stage. In
the second stage 120 records were independently
reviewed by a second pair of physicians.
Table 3: Description screening criteria for potential adverse events [1]
Screening criteria
Unplanned admission before index admission (admission reasons are related to the index admission)
Unplanned readmission after discharge from index admission
Hospital-incurred patient injury (Permanent or temporary injury obtained (acquired) during index admission)
Adverse drug reaction
Unplanned transfer from general care to (an) intensive care (unit)
Unplanned transfer to another acute care hospital (after unexpected deterioration of the patient)
Unplanned return to the operating room
Unplanned removal, injury or repair of organ during surgery
Hospital-acquired infection or sepsis
Other patient complication
Development of neurological deficit not present on admission
Unexpected death
Cardiac or respiratory arrest
Injury related to abortion or delivery
Inappropriate discharge to home
Dissatisfaction with care documented in the medical record
Documentation or correspondence indicating litigation
Any other undesirable outcome not covered aboveBMC Health Services Research 2007, 7:27 http://www.biomedcentral.com/1472-6963/7/27
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Confidentiality (Privacy)
In this study anonymity of hospitals, health care providers
and patients was of utmost importance. Several measures
were taken to ensure confidentiality of the collected infor-
mation. Reviewers and researchers (study staff) signed a
confidentiality agreement to maintain the secrecy of the
information. The reviewers never reviewed in hospitals
where they have ever been employed in the medical or
nursing staff and the reviewers would never contact indi-
vidual patients or physicians. During the data collection,
the records were never left unattended and they were
stored in a locked room.
Each admission received an unique study number so that
patients' identity would not be revealed. Patient identifi-
ers were kept in a dataset separately from the primary
database. During the review process in hospital, the data
were directly entered into a protected electronic database
ProMIse. The reviewers had a personal password for the
electronic database. The web-based database complied
with the safety and privacy requirements. Patients' names
were not included in the database and after completion of
the data collection and analysis, medical record identifiers
were destroyed. The identities of patients or physicians
would not be revealed in research reports.
If a reviewer had any concerns during the review process
about unrecognized potential deliberate harmful acts,
illegal acts, or repetitive negligent behaviour, these con-
cerns could be discussed with the ethics committee set up
for this study.
Ethical approval
The project and methods had been granted ethical
approval by VU University Medical Centre in Amsterdam.




The determination of adverse events was based on three
criteria (table 4). To determine whether the injury was
caused by health care a 6-point scale was used. Causation
scores of 4–6 were classified as adverse events. From each
adverse event found in this study the degree of preventa-
bility on a 6-point scale was measured and location,
involved speciality, involved healthcare providers, classi-
fication and causes were registered. Furthermore, patient
demographics such as age, sex, and social economic status
(obtained by postal code) and admission characteristics
like length of stay, admission status (elective, urgent,
transfer or readmission), admission and discharge diag-
nosis, admission specialty, discharge status (dead, alive
and discharge to home, home with outpatient care etc),
and procedures were collected. Most of the patient and
admission characteristics were provided by the participat-
ing hospitals from their hospital information system
(inpatient database). In addition, for the patients who
died during the index admission, the expected life time of
the patient, should the adverse event not have occurred,
was estimated by medical reviewers. The adequacy and
completeness of the documentation of each studied
record were judged by the reviewers.
Statistical analysis
During the data collection data checks (identify out-of-
range answers, inconsistent responses and missing data)
were performed on a regular basis. Data extracted from
ProMIse were analysed using SPSS 12.0 for Windows.
The national weighted average incidence of adverse events
in Dutch hospitals in categories of preventability was cal-
culated, corrected for oversampling of university hospitals
and of patients who died during hospital admission. Dif-
ferences in adverse event rates between hospital types, dis-
charge diagnoses and most responsible specialties were
calculated using multi level analysis when appropriate, in
order to disentangle variation at the patient and the hos-
pital level. Potentially confounding determinants, such as
age, sex, comorbidity, life-expectance and quality of the
patient record, were identified and differences in adverse
event rates between groups were adjusted for potentially
confounding determinants using multilevel multivariate
analysis. All incidence rates were calculated with 95%
confidence intervals. For the subgroup of patients who
died during admission, all analyses were replicated.
Direct medical costs associated with adverse events were
measured as excess length of stay and charges for excess
procedures during admission. For each admission in
which the patient was discharged alive, the expected
length of stay in hospital based on diagnosis, age and sex
was estimated based on national data and excess length of
stay was computed as the difference between actual length
of stay and expected length of stay. Dutch guideline prices
were used to value excess length of stay and procedures
[21]. If not available, cost-prices or tariffs were used. Costs
associated with adverse events were estimated using a lin-
ear regression model, adjusting for confounding factors
such as age, sex and comorbidity when appropriate.
The inter-rater reliability of the review process by nurses
and specialists was expressed as a kappa statistic with 95%
confidence intervals and as percentage of records for
which there was agreement. In the first stage the agree-
ment between nurses was measured for finding screening
criteria in the patient records. The kappa statistics in the
second stage was measured for the determination of the
degree of the injury, to what the degree the injury wasBMC Health Services Research 2007, 7:27 http://www.biomedcentral.com/1472-6963/7/27
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caused by health care management and to what degree the
adverse event was preventable.
Discussion
Strengths and limitations of this study
To address the need for empirical information regarding
the epidemiology of poor quality and iatrogenic injury,
the first large population-based retrospective medical
record study was developed in New York in 1984 (Har-
vard Medical Practice Study, HMPS) [2]. The HMPS estab-
lished a standard method by which adverse events are
measured and it formed the basis of political discussions
on patient safety in several countries [22]. This method
was proven valid to identify adverse events and estimate
their incidence in hospitals nation wide [17]. The HMPS
method has been used nation wide in Australia, the UK,
New Zealand, and Canada and has become the bench-
mark method for research on adverse events in hospitals
and for assessing the status of patient safety in hospitals
around the world [22]. Based on the results of the large
studies of patient records, areas with problematic patient
safety can be identified and specific patient safety actions
can be implemented. In short, the strengths of this
method are: effective for estimating adverse event inci-
dence; almost no workload for hospital staff; no incon-
venience for departments or interruptions of the health
care process, and the data collection is easy to plan [6]. By
using a highly similar protocol and instruments in our
study it is possible to compare our results with those from
previous (European) studies. With more than 8000
patient records, the Dutch study on the occurrence of
adverse events in hospitals is the largest retrospective
patient record study in Europe.
Although the results of these studies showed that the
instruments are sensitive for identifying adverse events
[17], some aspects can lead to an under- or overestimation
of the adverse event incident rate. The record review
method for identifying adverse events relies exclusively on
data from hospital records. Only events documented in
hospital records are included in the analysis and available
information of events in the records can be insufficient for
the adverse event determination [11,23] Without com-
plete follow-up information on the patient, absolutely
accurate estimates of disability are not possible [2]. This
may underestimate the rate of adverse events in hospitals.
In our study, the nurses and physicians assessed the com-
pleteness and adequacy of the records; also the relation
between the quality of the information in the records and
adverse events rate will be analysed. Insufficient records
were excluded from the study.
Another potential source of error is missing records. In the
HMPS the rate of adverse events in the missing records
Table 4: Outcome measurements [1,11]
Determination of the presence of an adverse event was based on three criteria:
1. an unintended (physical and/or mental) injury which
2. results in temporary or permanent disability, death or prolongation of hospital stay, and is
3. caused by health care management rather than the patient's disease
To determine whether the injury was caused by health care management or the disease process a 6-point scale was used:
1. (Virtually) no evidence for management causation
2. Slight to modest evidence of management causation
3. Management causation not likely (less than 50/50, but 'close call')
4. Management causation more likely (more than 50/50, but 'close call')
5. Moderate to strong evidence of management causation
6. (Virtually) certain evidence of management causation
The degree of preventability of the adverse events was measured on a 6-point scale, grouped into three categories:
No preventability
1. (Virtually) no evidence for preventability
Low preventability
2. Slight to modest evidence of preventability
3. Preventability not quite likely (less than 50/50, but 'close call')
High preventability
4. Preventability more than likely (more than 50/50, but 'close call')
5. Strong evidence of preventability
6. (Virtually) certain evidence of preventability
Timing of the adverse events in relation to index hospital admission.
The index hospital admission was the admission sampled. Adverse events were recorded if they occurred during the index admission and that 
were detected during or after the index admission over the following 12-month period. Or adverse events that were related to hospital admissions 
within the 12-month preceding the index admission but were not detected until the index admission (Figure 2).BMC Health Services Research 2007, 7:27 http://www.biomedcentral.com/1472-6963/7/27
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was measured by means of a follow-up study. The rates of
adverse events and negligence in the follow up study were
lower overall than in the initial survey [2]. In our study,
hospital records without nursing or medical record were
excluded and reasons why records were missing were
recorded. A follow-up study to assess the adverse event
rate in the missing records was not possible because of
practical reasons.
Adverse events revealed after discharge are captured if they
result in readmission to the hospital. If the patient is not
readmitted, the adverse event is not discovered unless it is
recorded in the hospital's outpatient record. It is not pos-
sible to estimate the number of adverse events that will be
missed, but most adverse events that cause major disabil-
ity or have a substantial financial impact probably require
hospitalisation [2]. Moreover, at some participating hos-
pitals in our study, it was not feasible to collect outpatient
records as they are stored in many different archives. The
lack of the outpatient records in some hospitals will lead
to an underestimation of the adverse events incidence or
of the effect.
Previous studies showed that adverse events can be iden-
tified accurately from information in hospital records,
however, such records may not provide evidence or
insight into the specific cause of an adverse event. The
record review method is not the most suitable instrument
to get insight into the specific cause of an adverse event
[23].
Validity
The internal and external validity of the record review
study depends on the representativeness of the selected
admissions. A non-representative sample can lead to
under- or overestimation. To ensure that all admissions
from 2004 were involved in the selection procedure, the
random samples of admissions in the participating hospi-
tals were taken from the hospital information system
rather than from records available in the archive depart-
ment. For each hospital representativeness of the sample
is verified by comparing general characteristics of selected
admissions with those of all admissions of the participat-
ing hospitals. If the selection of admissions was not repre-
sentative, a new random sample was selected. Before we
extrapolated the results of our study to all Dutch hospitals
the characteristics of the total sample of 8400 admissions
were compared with those of all admissions of all hospi-
tals in the Netherlands.
Reliability
Unlike injuries in the workplace or motor-vehicle acci-
dents, which usually occur in healthy people, medical
injuries in the hospital generally occur in those who are
already ill. Therefore, it is sometimes difficult to distin-
guish disabling injuries caused by medical interventions
from those attributable to the illness for which the patient
is being treated. It can also be difficult to distinguish
between injuries resulting from errors and those that
could not reasonably have been prevented [24]. Thus,
even with the carefully structured review process, there
may still be substantial variation in the judgments of phy-
sician reviewers. Reliability estimates on the assessment of
adverse events were only moderate in previous studies;
those relating to the degree of impairment attributable to
the adverse event were even lower [22].
In our study, several efforts were made to reduce the inter
reviewer variation of the review process. Like the Cana-
dian protocol, experienced nurses and physicians were
recruited. They received a standardized training and a
manual in which the research protocol, instruments and
definitions were defined. During the study, reviewer per-
formance was monitored and they received personal feed-
back. The use of electronic review forms and data from
hospital information systems also enhanced the efficiency
of the study and the reliability of the measurements. The
electronic review form ensured complete data entry and
computerized hospital data of the patients were trans-
ported into the electric forms in advance. This improved
the completeness and quality of the data collection.
On top of the efforts from the Canadian protocol several
activities were undertaken in our study to enhance the
accuracy of the reviews. During the research process the
reviewers could discussed their problems concerning the
review process, cases and definitions in regularly organ-
ised discussion meetings. The questions and discussed
problems were noted in a regularly updated frequently
asked questions list. The precision of the reviews also
depends on the efficiency of the design. For that purpose,
in our study the reviewers had to focus on their own
expertise: nurses concentrated on the nursing records;
physicians examined mainly the medical records and the
self-stick notes of the nurses in the nursing records. More-
over, four different specialties were involved for the med-
ical review instead of two: general internists, general
surgeons, neurologists and paediatricians. Records with,
for example, neurological screening criteria were reviewed
in the second stage by two neurologists. And for questions
about accepted clinical practice the physicians could con-
sult an expert panel of medical specialists. In the second
stage all records were reviewed by two physicians instead
of one. The consensus procedure and involvement of a
third reviewer (in case of disagreement after the consensus
procedure) should lead to a more reliable measurement.
Modifications of protocol and instruments
The protocol and instruments used in this record review
study were adapted from the Canadian record reviewBMC Health Services Research 2007, 7:27 http://www.biomedcentral.com/1472-6963/7/27
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study [1]. As a result of the Dutch pilot study, some mod-
ifications were made in the protocol and the instruments
for the Dutch Adverse event Study [16].
￿ Selection of hospital admissions
The Dutch study included patients older than one year
and oversampled deceased patients. In the Canadian
study only patients over 18 years old were included and
there was no oversampling for deceased patients. For this
reason paediatricians were involved in the medical review
of the record review process. The oversampling of
deceased patients enables us to determine better the inci-
dence of preventable deaths. Moreover, the incidence of
adverse events is expected to be higher in this group,
which makes the study more efficient.
￿ Review instrument
In the review form of the second stage we have changed
some components and added some questions. The classi-
fication categories of the types of adverse events were
changed and the questions for the medication related
adverse events were made more specific. To get more
insight into the causes of the measured adverse events the
questions about the contributing factors were more
extended and structured according to the PRIMSA classifi-
cation of causes of incidents [25]. In the section 'quality of
the record' questions about autopsy were added. Brennan
(1991) wrote that the judgments of physicians that an
adverse event has led to death also require a note of cau-
tion. Many patients who died after an adverse event had
very serious underlying diseases, and several surely had
shortened life expectancies independent of their iatro-
genic injury [2]. In our study, the number of days of life
lost as a result of the adverse event in the case of a termi-
nally ill person was estimated to study the relation
between the occurrence of adverse events and life expect-
ancy. To improve the efficiency and quality of the data
collection, control and analysis, the collected patient
information was transported to a central database with a
web-based program.
The changes in the protocol and the instrument are
focussed on the improvement of the quality, efficiency
and reliability of the adverse events determination and
their preventability. In spite of these changes, comparison
of the results of this study with the results of previous
studies is still possible.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
MZ wrote the manuscript, prepared the protocol and
instruments of the study, and collected and analysed data.
MB contributed to the manuscript, is the general supervi-
sor of the retrospective record study, contributed to the
design and conception of the study, and coordinated the
study.
CW is the general supervisor of the Dutch patient safety
research program and research group, contributed to the
design and conception of the study, and contributed to
the manuscript.
RW has developed the review forms within the web-based
program ProMIse, managed the acquisition of data, facil-
itated data control during and after data collection and
contributed to the statistical data analysis.
PG has been involved in revising the article critically for
important intellectual content.
GW contributed to the design and conception of the study
and has been involved in revising the article critically for
important intellectual content (former general supervisor
of the Dutch patient safety research program and research
group).
Timing adverse event (occurrence and detection of AE) Figure 2
Timing adverse event (occurrence and detection of AE). 0 = Occurrence AE, X = detection AE.
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